January 24, 2019 Acad, Gov/Utilities Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10

Shimadzu announces a New Research Facility to drive innovation further as part of the Shimadzu Technology Research Laboratory expansion.

Shimadzu Corporation has announced plans to build the SHIMADZU Future Collaboratory at the Technology Research Laboratory in Keihanna Science City, Kyoto Prefecture, Japan to expand the program of innovation at Shimadzu Corporation. The new laboratory will further drive research and development by focusing on several core themes including artificial intelligence (AI), innovative biotechnology, brain-science and... Read more

January 23, 2019 Clinical Research/Diagn. M&A, Partnerships

G-CON Manufacturing and GE Healthcare Announce Collaboration to Advance Early-Stage Cell Therapy and Viral Vector Manufacturing

College Station, TX and Chicago, IL, US, January 23 2019 – G-CON Manufacturing, the leader in prefabricated flexible cleanroom solutions (“PODs”) and GE Healthcare plan to collaborate to improve cell therapy and viral vector manufacturing by providing drug developers with a combined, flexible, and readily deployable manufacturing platform suitable for early-stage clinical or commercial production.... Read more

January 17, 2019 Clinical Research/Diagn. Licensing, IP, and Legal Microscopy

Miltenyi Biotec acquires promising non-harmful imaging process

BERGISCH GLADBACH,  Jan 17, 2019 – Miltenyi Biotec GmbH, a global provider of products and services for biomedical research and cellular therapy, announced that it has signed a purchase contract for a non-harmful, fluorescence-preserving, optical clearing process from the University of Duisburg-Essen, Germany. The acquired invention involves an easy-to-use protocol that allows a safe optical clearing... Read more

January 16, 2019 Clinical Research/Diagn. PR/Corporate

QIAGEN receives approval for EGFR test in lung cancer as companion diagnostic in Japan

Hilden, Germany, and Tokyo, Japan, January 16, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the Japanese Pharmaceuticals and Medical Device Agency (PMDA) has approved the therascreen® EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer’s VIZIMPRO® (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent... Read more

January 16, 2019 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Merck KGaA, Darmstadt, Germany, Welcomes Ten New Startups to its Innovation Center

From January 2019, startups from nine different countries will collaborate with Merck KGaA, Darmstadt Germany Selected teams will have the opportunity to extend their stay in the company’s China Innovation Hub in Shanghai For the first time, the program includes a startup specializing in the fight against multi-drug resistant bacteria Darmstadt, Germany, January 16, 2019... Read more

January 14, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Product Launch

QIAGEN’s QuantiFERON®-TB Gold Plus gains approval in Canada

Germantown, Maryland and Hilden, Germany, January 14th, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Health Canada regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic test to detect latent tuberculosis (TB) infection. QFT-Plus is the fourth generation of QIAGEN’s market-leading QuantiFERON-TB technology, combining a new flexible... Read more

January 9, 2019 Clinical Research/Diagn. Product Launch

Roche launches new cobas pro integrated solutions to significantly reduce manual operations in labs

cobas pro integrated solutions enhances automated procedures to overcome key challenges in lab management This new Serum Work Area solution in the cobas family minimizes hands-on time and maximizes productivity through automated procedures This new innovation offers flexibility for future changing testing needs, enabling labs to further deliver quality patient care  Basel, 9 Jan. 2019 Roche (SIX: RO,... Read more

January 8, 2019 Clinical Research/Diagn. Liq. Handling & Robotics Product Launch

The World’s First Fully Automated Plate-Based Robotic Solution for High Precision in Endotoxin Detection

Walkersville, MD (USA) / Basel, Switzerland, 08 January 2019 – Lonza will unveil PyroTec™ PRO, the first-ever fully automated, plate-based robotic solution for endotoxin detection at SLAS2019 International Conference and Exhibition (2-6 February, Washington, DC, USA). Integrated with the latest version of Lonza’s proprietary dynamic control WinKQCL™ 6.0 Software platform, the new system has been... Read more

January 8, 2019 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Shimadzu Medical Systems USA acquires Core Medical Imaging, Inc. to strengthen Healthcare Business in North America

TORRANCE, Calif., Jan. 7, 2019 /PRNewswire/ — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation (hereinafter “Shimadzu”), in order to further expand its Healthcare Business in North America, has acquired CORE Medical Imaging, Inc. (hereinafter “CMI”). CMI, with its head office in Kenmore, WA, has successfully provided medical imaging products and service as an authorized dealer of several professional... Read more